| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ARVINAS, INC. | Chief Financial Officer | Common Stock | 181,916 | $8,559,148 | $47.05 | 23 Feb 2024 | Direct |
| HOOKIPA Pharma Inc. | Director | Stock Option (Right to Buy) | 9,800 | 22 Jul 2024 | Direct | ||
| ARVINAS, INC. | Chief Financial Officer | Restricted Stock Units | 0 | 01 Mar 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| HOOK | HOOKIPA Pharma Inc. | 22 Jul 2024 | 1 | $0 | 4 | Director | 24 Jul 2024, 16:16 |
| HOOK | HOOKIPA Pharma Inc. | 22 Jul 2024 | 0 | $0 | 3 | Director | 24 Jul 2024, 16:15 |
| ARVN | ARVINAS, INC. | 23 Feb 2024 | 1 | -$80,079 | 4 | Chief Financial Officer | 27 Feb 2024, 18:34 |
| ARVN | ARVINAS, INC. | 01 Mar 2023 | 3 | -$51,530 | 4 | Chief Financial Officer | 03 Mar 2023, 20:49 |
| ARVN | ARVINAS, INC. | 22 Feb 2023 | 2 | $0 | 4 | Chief Financial Officer | 24 Feb 2023, 15:59 |
| ARVN | ARVINAS, INC. | 11 Mar 2022 | 3 | -$1,050,000 | 4 | Chief Financial Officer | 15 Mar 2022, 20:00 |
| ARVN | ARVINAS, INC. | 23 Feb 2022 | 4 | -$101,856 | 4 | Chief Financial Officer | 04 Mar 2022, 20:00 |
| ARVN | ARVINAS, INC. | 17 Dec 2021 | 3 | -$810,000 | 4 | Chief Financial Officer | 21 Dec 2021, 20:15 |
| ARVN | ARVINAS, INC. | 28 Jul 2021 | 3 | -$1,448,328 | 4 | Chief Financial Officer | 30 Jul 2021, 20:05 |